“car-t” Archives

in
Entry Author Date Location
Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold 08/18/20 San Diego
GlaxoSmithKline Multiple Myeloma Drug Earns FDA’s First Anti-BCMA Nod 08/06/20 National
3 Biotech IPOs Together Rake In Over a Half Billion to Advance Treatments 07/13/20 National
Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs 07/07/20 Boston
Artiva Bio Raises $78M to Broaden Access to Cancer Cell Therapies 06/26/20 San Diego
From Overseas, Legend Biotech and Calliditas Therapeutics Eye the Nasdaq 05/15/20 New York
Adicet Aims to Advance CAR-T Therapies in Reverse Merger with resTORbio 04/29/20 Boston
Synthorx’s Shawver Joins Silverback Therapeutics as New Top Exec 04/22/20 Seattle
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
Eureka Partners With Lyell to Tackle Tricky Solid Tumor Cell Therapies 03/20/20 San Francisco
Amunix Raises $73M to Bring Safer T Cell Engagers to Solid Tumors 03/04/20 San Francisco
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019 02/12/20 National
Scripps Research’s Calibr to Test “Switchable” CAR-T in Clinical Trial 02/06/20 San Diego
Incyte Commits $900M to MorphoSys for Rights to Lymphoma Drug 01/13/20 National
Allogene, SpringWorks to Test Drug Combo in Multiple Myeloma Trial 01/13/20 San Francisco
Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer 12/10/19 San Diego
Led by Gilead Veteran Riva, Glenmark’s Ichnos Steps Out on Its Own 10/15/19 New York
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight 08/28/19 New York
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work 08/08/19 Boston
Gilead Ups Stake in Galapagos With $5B Deal to Jumpstart Its R&D 07/15/19 San Francisco
Neon’s Early Vaccine Study Is a Peek at Immunotherapy’s Third Wave 07/15/19 Boston
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More 07/12/19 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More 06/05/19 National
Inhibrix Pulls In $40M to Press Ahead With Cancer Drug Clinical Trials 05/24/19 San Diego
Poseida to Advance CAR-T For Myeloma with Novartis-Led $142M Round 04/22/19 San Diego
Another Week, Another Gene Therapy Buyout: Catalent Pays $1.2B for Paragon 04/15/19 New York
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout 04/12/19 New York
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results 04/03/19 National
Page 1 of 7 next page »